CENTRAL LABORATORIES FEATURED ARTICLES
CENTRAL LABORATORIES WHITE PAPERS & ARTICLES
-
![data-cleaning-clinical-trialls]( "Hidden Costs Of Data Cleaning: Build Quality At The Source")
Hidden Costs Of Data Cleaning: Build Quality At The SourceHidden costs from downstream data cleaning slow trials and raise risk. Explore why building quality at the source accelerates timelines, reduces errors, and gives sponsors a competitive edge.
-
![ai-clinical-trials-tech]( "Aligning Global Standards For ICH E6(R3) And Artificial Intelligence")
Aligning Global Standards For ICH E6(R3) And Artificial IntelligenceGlobal standards and AI are transforming clinical research. Learn why mastering ICH E6(R3) and risk-based compliance is critical for data integrity and future success.
-
![GettyImages-1054148730-clinical-outsourcing-partner-FSP]( "ISCTM 2025 Findings To Strengthen Clinical Trial Rigor")
ISCTM 2025 Findings To Strengthen Clinical Trial RigorExplore how these insights can elevate CNS trial design, strengthen data integrity, and inspire more efficient, reliable methods that advance clinical research with greater confidence.
-
![GettyImages-576919878-analytics-computer-testing-research-data]( "Transforming An Atopic Dermatitis Trial")
Transforming An Atopic Dermatitis TrialDiscover how integrated data monitoring and targeted rater training can bolster consistency, reduce risk, and enhance confidence in clinician-rated dermatology trials across global development programs.
-
![GettyImages-1354172647-scientist-in-lab-with-flasks-pipette]( "Clinical Trial Starts Rose At Slower Pace In 2024")
Clinical Trial Starts Rose At Slower Pace In 2024Clinical trial starts grew 5.5% to 10,503 in 2024, a slowdown from 2023’s 9.4% rise in trial starts. Sustained geopolitical and global regulatory pressures on pharma contributed to curbing momentum.
CENTRAL LABORATORIES APPLICATIONS & STUDIES
-
Drilling Down On Diversity And Feasibility12/8/2025
A mid-sized contract research organization (CRO) sought help with writing clinical trial diversity action plans and assessing feasibility for therapeutic areas outside its usual scope.
-
Accelerating Clinical Data Review With Traceable Workflows12/3/2025
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
Rescuing Data Integrity: A Swift Transition And Quality Transformation11/14/2025
Uncover how this collaboration supported timely progress toward key study milestones, enabling smoother execution and more dependable output across data management and statistical activities.
-
Effect Of Etrasimod On Immune Cell Subsets In Colonic Tissue9/25/2025
Etrasimod selectively modulates S1P receptors to reduce inflammation and immune cell trafficking to the gut, showing promise in treating moderate to severe ulcerative colitis.
-
Streamlining Global Respiratory Trial Complexities With Robust Data Capture Strategy9/23/2025
Want to see how eCOA solutions can simplify patient-reported data capture and accelerate global trials? Explore implementation strategies, lessons learned, and measurable results.
CENTRAL LABORATORIES PRODUCTS & SERVICES
The Australian Advantage is about saving time and minimizing costs while generating internationally accepted data in preparation for the next Phase.
Shape crucial market choices and value substantiation with the depth and breadth of integrated clinical EHRs, claims, and patient reported outcome data, backed by analytical and therapy area expertise.
The Revvity Signals Software Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.
Enabling organizations of all sizes to transform their business through better use of technology.
Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.
ProPharma has deep expertise across all signal detection and management activities, including validation, prioritization, and assessment using data from a wide range of sources that are relevant for signal detection for the individual product(s). We are also fully trained and experienced in the EudraVigilance Data Analysis System (EVDAS) functionality and can support MAHs to comply with their obligations for signal detection and management. We leverage our robust knowledge to select the most efficient and effective method(s) for each product that is compliant with legislative requirements.
The ISPOR Education Center provides instant access to Health Economics and Outcomes Research (HEOR) education with on-demand programs delivered through a personalized, powerful, and flexible learning platform. Working at their own time and pace, individuals can drive their professional development by growing their knowledge and skills with topical, relevant, and innovative course curricula.
CENTRAL LABORATORIES SOLUTIONS
- Risk-Based Monitoring
- Choose An Oncology Offering Designed Around Patient Experience
- Launch Strategy & Planning
- Oncology Solutions
- Clinical Data Review Analytics Solution
- RWD & Human Insight From Consulting & Analytics
- Financial Scenario Planning
- Technology Solutions And Services Tailored For Emerging Biopharma
- Wearable Device Comparison Guide: Medical-Grade Or Consumer Device?
- Leading The Way In Patient Payments
VIDEOS
- Revolutionize Data Access With An AI Powered Custom Listing Generator
- How AI-Enhanced CAPA Systems Cut Non-Conformances By Targeting Root Causes
- The Industry’s First And Only Unified Platform For RWE Generation
- AI Importer — See It in Action!
- Protect Personally Identifiable Information (PII) With My Medidata
NEWS
- Integrating Lyft Healthcare As An Affordable On-Demand Transportation Provider For Clinical Trial Participants: A Move Towards Enhanced Patient Experience
- Yoncare s.r.o. Partners With Block Clinical Inc. To Deliver EU-Centric Clinical Trial Participant Travel And Payment Services In Europe
- Block Clinical Discusses Patient Travel Support With Panel Members
- Quotient Sciences And Intrepid Labs Form Strategic Partnership To Accelerate AI-Guided Formulation Development
- One App To Simplify The Clinical Trial Journey
- Avance Clinical Showcases Early Phase Expertise And The Australian Advantage For EU Biotechs At BIO-Europe Vienna
- Meet Avance Clinical At SCOPE Summit 2026 In Orlando, Florida
- Signant Health Appoints Internationally Recognized Cognitive Assessment Expert John Harrison To Further Advance Innovation In CNS Clinical Trials
- Avance Clinical Launches Renal And Cardiometabolic Center Of Excellence To Optimize Patient Recruitment To Elevate Study Success
- Avance Clinical Unveils Dedicated CNS Center Of Excellence For Expert Clinical Trial Services In Neuroscience
- Suvoda Expands EU Patient Travel with Bolt Partnership
- Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
- Castor Catalyst: Launching Self-Driving Clinical Trials With Google Cloud AI
- Almac Trial Coordinator Launched In $48 Million Investment To Advance Integrated eClinical Technologies
- Quotient Sciences And Biorasi Partner To Accelerate Early Phase Clinical Trials To Patient Proof-Of-Concept
- Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions
- Suvoda And Greenphire Complete Brand Integration With Unified Website And Social Media Presence
- Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs
- Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.
- Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration
- "Most-Favored Nation" Drug Pricing Strategy May Backfire, New Research Warns
- ISPOR Real-World Evidence Summit 28-30 September 2025, Tokyo, Japan
- Ametris Expands Collaborative Research Project To Investigate Digital Measures Of Physical Function For Drug Development in Obesity
- Quotient Sciences And CPI To Accelerate RNA Drug Development With Joint Venture
- Biorasi And Ryght AI Partner To Revolutionize Clinical Trial Feasibility With Real-Time AI Insights
- PCM Trials, EmVenio Research, And Clinical Trial Service Rebrand As EmVenio Clinical Research
- CORE 2025 - October 6-8, 2025
- Crucial Data Solutions Names Dr. Leigh J. Mack Chief Medical Officer Amid Industry AI Shift
- ISPOR Champions Research Transparency With Launch Of Open Science Badges
- Introducing Arcinova, A Quotient Sciences Company